Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Natural Capsules Limited ( (IN:NATCAPSUQ) ) has shared an announcement.
Natural Capsules Limited reported its financial results for Q1FY26, highlighting a revenue of ₹45.20 Cr and an EBITDA of ₹0.32 Cr with margins at 0.71%. Despite a stable quarter for its capsules business, the company plans to capitalize on rising demand for HPMC capsules due to US duties on Chinese imports by expanding production lines. The API segment shows signs of improvement, with increased realisations for steroidal APIs, and the company aims to achieve cash breakeven at its API facility by the end of Q2. These strategic moves are expected to drive growth and improve profitability.
More about Natural Capsules Limited
Natural Capsules Limited is a leading Indian manufacturer of hard capsule shells, known for pioneering vegetarian capsules in India. It is the second largest manufacturer of gelatin capsules in the country and has expanded its operations to include API manufacturing through its subsidiary, Natural Biogenex Private Limited.
Average Trading Volume: 2,178
Technical Sentiment Signal: Sell
Current Market Cap: 2.21B INR
Learn more about NATCAPSUQ stock on TipRanks’ Stock Analysis page.